Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation

NCT07382024 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation Ablation
Persistent Atrial Fibrillation
Obesity & Overweight

Interventions

DRUG: Tirzepatide
OTHER: Standard Care (in control arm)

Sponsor

National Taiwan University Hospital